Raphael Sandaltzopoulos, PhD, MBA Professor at MBG (Molecular Biology) Lab. of Gene Expression, Molecular Diagnosis and Modern Therapeutics,

Slides:



Advertisements
Similar presentations
Regulation of Consumer Tests in California AAAS Meeting June 1-2, 2009 Beatrice OKeefe Acting Chief, Laboratory Field Services California Department of.
Advertisements

ASSESSING RESPONSIVENESS OF HEALTH MEASUREMENTS. Link validity & reliability testing to purpose of the measure Some examples: In a diagnostic instrument,
Predictive Analysis of Gene Expression Data from Human SAGE Libraries Alexessander Alves* Nikolay Zagoruiko + Oleg Okun § Olga Kutnenko + Irina Borisova.
Understanding Statistics in Research Articles Elizabeth Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management Assistant Professor,
Module 6 “Normal Values”: How are Normal Reference Ranges Established?
From the homework: Distribution of DNA fragments generated by Micrococcal nuclease digestion mean(nucs) = bp median(nucs) = 110 bp sd(nucs+ = 17.3.
Evaluating Diagnostic Accuracy of Prostate Cancer Using Bayesian Analysis Part of an Undergraduate Research course Chantal D. Larose.
What is a sample? Epidemiology matters: a new introduction to methodological foundations Chapter 4.
EPIDEMIOLOGY AND BIOSTATISTICS DEPT Esimating Population Value with Hypothesis Testing.
Model and Variable Selections for Personalized Medicine Lu Tian (Northwestern University) Hajime Uno (Kitasato University) Tianxi Cai, Els Goetghebeur,
CS 8751 ML & KDDEvaluating Hypotheses1 Sample error, true error Confidence intervals for observed hypothesis error Estimators Binomial distribution, Normal.
Darlene Goldstein 29 January 2003 Receiver Operating Characteristic Methodology.
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
3 rd Summer School in Computational Biology September 10, 2014 Frank Emmert-Streib & Salissou Moutari Computational Biology and Machine Learning Laboratory.
Today Concepts underlying inferential statistics
Thoughts on Biomarker Discovery and Validation Karla Ballman, Ph.D. Division of Biostatistics October 29, 2007.
Inferential Statistics
Proteomics Informatics – Data Analysis and Visualization (Week 13)
Statistics in Screening/Diagnosis
Multiple Choice Questions for discussion
Apostolos Zaravinos, Myrtani Pieri, Nikos Mourmouras, Natassa Anastasiadou, Ioanna Zouvani, Dimitris Delakas, Constantinos Deltas Department of Biological.
UOG Journal Club: January 2013
Differential Analysis & FDR Correction
Analyzing Reliability and Validity in Outcomes Assessment (Part 1) Robert W. Lingard and Deborah K. van Alphen California State University, Northridge.
Basic statistics 11/09/13.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Indices of Performances of CPRs Nicola.
EDRN Approaches to Biomarker Validation DMCC Statisticians Fred Hutchinson Cancer Research Center Margaret Pepe Ziding Feng, Mark Thornquist, Yingye Zheng,
Reliability of Screening Tests RELIABILITY: The extent to which the screening test will produce the same or very similar results each time it is administered.
BIOMARKERS Diagnostics and Prognostics. OMICS Molecular Diagnostics: Promises and Possibilities, p. 12 and 26.
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008
Bioinformatics Expression profiling and functional genomics Part II: Differential expression Ad 27/11/2006.
EMBC2001 Using Artificial Neural Networks to Predict Malignancy of Ovarian Tumors C. Lu 1, J. De Brabanter 1, S. Van Huffel 1, I. Vergote 2, D. Timmerman.
Apostolos Zaravinos and Constantinos C Deltas Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological.
Metabolomics Metabolome Reflects the State of the Cell, Organ or Organism Change in the metabolome is a direct consequence of protein activity changes.
The Use of Predictive Biomarkers in Clinical Trial Design Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute
1 Risk Assessment Tests Marina Kondratovich, Ph.D. OIVD/CDRH/FDA March 9, 2011 Molecular and Clinical Genetics Panel for Direct-to-Consumer (DTC) Genetic.
Using Predictive Classifiers in the Design of Phase III Clinical Trials Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute.
Evaluating Results of Learning Blaž Zupan
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
Class 23, 2001 CBCl/AI MIT Bioinformatics Applications and Feature Selection for SVMs S. Mukherjee.
Innovative Paths to Better Medicines Design Considerations in Molecular Biomarker Discovery Studies Doris Damian and Robert McBurney June 6, 2007.
Diagnostic Tests Studies 87/3/2 “How to read a paper” workshop Kamran Yazdani, MD MPH.
Blood and Tissue Based Molecular Signatures in Predicting Prostate Cancer Progression Tarek A. Bismar, MD Professor, University of Calgary Departments.
Comp. Genomics Recitation 10 4/7/09 Differential expression detection.
Introducing Communication Research 2e © 2014 SAGE Publications Chapter Seven Generalizing From Research Results: Inferential Statistics.
Organization of statistical research. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and.
Assessing Responsiveness of Health Measurements Ian McDowell, INTA, Santiago, March 20, 2001.
10 May Understanding diagnostic tests Evan Sergeant AusVet Animal Health Services.
Establishment and verification of miRNAs expression molecules for breast cancer and its distant metastasis Yanhong Gao Associate Professor Department of.
Pan-cancer analysis of prognostic genes Jordan Anaya Omnes Res, In this study I have used publicly available clinical and.
P Values - part 2 Samples & Populations Robin Beaumont 2011 With much help from Professor Chris Wilds material University of Auckland.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
26134 Business Statistics Week 4 Tutorial Simple Linear Regression Key concepts in this tutorial are listed below 1. Detecting.
Statistical Inference for the Mean Objectives: (Chapter 8&9, DeCoursey) -To understand the terms variance and standard error of a sample mean, Null Hypothesis,
Direct method of standardization of indices. Average Values n Mean:  the average of the data  sensitive to outlying data n Median:  the middle of the.
Kelci J. Miclaus, PhD Advanced Analytics R&D Manager JMP Life Sciences
Raphael Sandaltzopoulos, PhD, MBA
Gene expression.
Understanding Results
Integrated microRNA-mRNA profiling identifies molecular biomarkers in bladder outlet obstruction-induced lower urinary tract dysfunction Fiona C. Burkhard1,
European Urology Focus
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Practical clinical chemistry
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Introduction to Instrumentation Engineering
ERRORS, CONFOUNDING, and INTERACTION
Diagnostics and Prognostics
Serum LAMC2 levels in pancreatic adenocarcinoma (PDAC) and other samples from Japan. Serum LAMC2 levels in pancreatic adenocarcinoma (PDAC) and other samples.
Presentation transcript:

Raphael Sandaltzopoulos, PhD, MBA Professor at MBG (Molecular Biology) Lab. of Gene Expression, Molecular Diagnosis and Modern Therapeutics, MBG, DUTH BIOMARKERS DISCOVERY: An introduction

What is a Biomarker? Biomarker is a measured characteristic which may be used as an indicator of a certain biological state or condition. Biomarker is a measureable characteristic which may be used as an indicator of a certain biological state or condition. Measureable: ease of sampling, reliability, reproducibility and accuracy of detection method. Indicator: robust correlation with biological condition.

A good Biomarker shows a robust correlation with a certain biological condition. Pearson correlation: How tightly does the value of one parameter correlate with the value of another parameter? Difference of average: Is a value of a parameter significantly different among two groups which are defined by the value of a second parameter?

Expression of T-lymphocyte markers (mRNA) is a reliable indicator of CD8+ T-lymphocyte infiltration in ovarian tumors CD3 staining CD8 staining Example of difference of average (one or two-tailed t-test)

TTF1 is overexpressed in TIL+ Epithelial Ovarian Cancer ttf1 mRNA was quantified by qPCR in 45 ovarian tumors (classified as TIL+ or TIL-). mRNA levels were higher in TIL+ compared to TIL- samples (p=0.039).

TTF1 expression correlates with T-cell infiltration  qPCR analysis of the relative expression of ttf1 and cd8a mRNA in 96 ovarian cancer samples, verified a significant correlation (Pearson correlation=0.329, p<0.01). Example of Pearson correlation analysis

TMEM132D is over-expressed in TIL+ Epithelial Ovarian Cancer TMEM132D: Single-pass type I transmembrane protein. May serve as a cell- surface marker for oligodendrocyte differentiation. Implicated in anxiety disorders. Example of Pearson correlation analysis 95% Confidence Interval: If we were to repeat the sampling 100 times and calculate a population of 100 r values, the population mean would probably lie between and  95% of the time, the confidence intervals contain the true mean.

Common pitfalls of correlation analysis Correlation and causality: a. Correlation does not necessarily imply causality.

Common pitfalls of correlation analysis Correlation and causality: b. Normal distribution and lack of correlation does not necessarily imply independence. X and Y are uncorrelated; Both have the same normal distribution; X and Y are not independent.

Common pitfalls of correlation analysis Correlation and linearity: c. Correlation does not necessarily imply linearity Four sets of data with the same correlation of 0.816

The nature of a Biomarker

Adapted from Kaiser J, Science 330:576.

The nature of a Biomarker

Technology platforms commonly used in Biomarkers’ Discovery

In silico Biomarkers disparate data resources advanced bioinformatics modeling Biomarkers discovered by data analysis and mining workflows and algorithms capable of working with disparate data resources in the areas of gene expression, copy number, pathway networks, miRNA, and metabolomics data, next generation sequencing (NGS) data including RNA-seq, ChIP-seq, whole genome, exome, and others, using advanced bioinformatics modeling and development of analytics.

The biomarker evolution pathway in translational medicine

An example of Risk Score Assessment of microRNA Biomarkers in NSCLC Adapted from Zander et al, 2011, Clin. Cancer Res 11:3360. Risk score = 0,969 x miR ,973 x miR30d - 0,650 x miR1 - 0,815 miR499

Sensitivity: The fraction of people with the disease that the test correctly identifies as positive. Specificity: The fraction of people without the disease that the test correctly identifies as negative. A “good” Biomarker has a great combination of sensitivity and specificity

Receiver Operating Characteristic (ROC) curve A receiver operating curve (ROC) is a plot of sensitivity versus 1-specificity. The name is derived from its original use in radar technology. The dotted line represents a useless test that has no discriminatory power. The size of the area between the dotted line and the solid line in the ROC curve reflects the ability of a test to discriminate between diseased and non-diseased individuals across the range of potential cut-offs.ROC curve

Receiver Operating Characteristic (ROC) curve Test value Cutoff value chosen to minimize inclusion of false positives. (for example when treatment is expensive or invasive). Cutoff value chosen at statistical mean. Equal number of true positive missed as the number of people diagnosed as false positive. The cutoff value is chosen to minimize missing true positives, thus including more false positives. (for example: when consequences of missing a case are serious, e.g. testing potential blood donors for HIV). Setting the criterion value is a compromise between sensitivity and specificity.

Area Under Curve (A.U.C.) as a measure of a Biomarker’s usefulness Test value Large distribution of measured values between the diseased and the non-diseased populations make it easy to choose a cut off value. Small difference in distribution of measured values between the diseased and the non-diseased populations make it very difficult to choose a cut off value.

81 patients, 46 benign 27 healthy women * - p<0,05; ** - p<0,01; *** - p<0,001. Serum concentration of endothelial markers

117 patients, 59 benign * - p<0,05; ** - p<0,01; *** - p<0,001. Validation in an independent group of patients

ROC analysis: better Diagnostics by combination of biomarkers

The Kaplan-Meier estimator for the survival function from lifetime data. Used to measure the fraction of patients living for a certain amount of time after treatment. A Kaplan–Meier plot of the survival function is a series of horizontal steps of declining magnitude which, when a large enough sample is taken, approaches the true survival function for the population. censored data Advantage of the Kaplan–Meier curve: It takes into account some types of censored data, particularly right-censoring, which occurs if a patient withdraws from a study, i.e. is lost from the sample before the final outcome is observed. On the plot, small vertical tick-marks indicate losses, where a patient's survival time has been right-censored.

Overview of Multi-omic Approaches Applied in Biomarker Discovery

Sectors of Biomarkers applications in medicine

Biomarkers in personalized treatment

Qualities of a good Biomarkers in diagnosis and therapy Discrimination of healthy/deseased speciments (sensitivity and specificity). Easily detectable and quantifiable. Simple (not a combination of many factors). Extracellular (secreted) or cell surface. Presence/expression in a restricted tissue, cell type as a result of a certain condition. Minimal influence by irrelevant factors. Consistent behavior within a population.